I seriously hope so. Tens of millions have given their dna to a company who processes their samples overseas and operates with no concerns of hipaa or other frameworks. Horrible
-
-
-
do they process them overseas?
Kraj razgovora
Novi razgovor -
-
-
Or will sequencing prices fall enough to create a second wave of recreational genomics as genotypers go for whole genome sequencing? The big weakness in the
@23andMe business model has been that there are no repeat customers -
They'll sell the data to third parties - that was the model all the way. Who's the customer when the cost of the report is about the cost of the sequence?
- Još 1 odgovor
Novi razgovor -
-
-
Security. Not just in protection of the data from unwanted access, but in promising the data is not being shared with anyone in any form without individual approval ... every single time you want to use it. Plus if you get bought everyone has a right to have their data destroyed.
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
-
-
By this point, many of the early, interested adopters have likely used the platform, and with limited medical utility, it's a harder sell to the rest of the masses.
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
-
-
Probably only in its iteration currently. The whole "discover who you are" is the opposite of an Evergreen product, and a majority of the people who are likely to be interested have taken the test and shared the results (also not a product you can share with family)
-
Current approaches to outreach (free tests to YouTubers, medical advertisements etc) are reaching an end, hence the layoffs I would imagine, but I cannot imagine the desire for and utilisation of said data is going anywhere anytime soon, especially not with Google money, my 2¢.
Kraj razgovora
Novi razgovor -
-
-
Probably just automating parts of the workforce away.
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
-
-
No, it just means building a drug discovery empire on 500K SNP arrays was...not the smartest bet
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.